Endocannabinoid system modulator use in everyday clinical practice in the UK and Spain.
about
Evidence for the efficacy and effectiveness of THC-CBD oromucosal spray in symptom management of patients with spasticity due to multiple sclerosisTerpenes and lipids of the endocannabinoid and transient-receptor-potential-channel biosignaling systemsA Sativex(®) -like combination of phytocannabinoids as a disease-modifying therapy in a viral model of multiple sclerosis.Pharmacokinetic evaluation of nabiximols for the treatment of multiple sclerosis pain.Multiple sclerosis spasticity management--key publications.Advances in the management of multiple sclerosis spasticity: experiences from recent studies and everyday clinical practice.Delta-9-tetrahydrocannabinol/cannabidiol (Sativex®): a review of its use in patients with moderate to severe spasticity due to multiple sclerosis.Evaluation of the tolerability and efficacy of Sativex in multiple sclerosis.Effect of Sativex on spasticity-associated symptoms in patients with multiple sclerosis.Efficacy and safety of nabiximols (Sativex(®)) on multiple sclerosis spasticity in a real-life Italian monocentric study.Interaction of Plant Extracts with Central Nervous System ReceptorsDrug-resistant MS spasticity treatment with Sativex(®) add-on and driving ability.Therapeutic potential of medicinal marijuana: an educational primer for health care professionals.
P2860
Q26770823-E9A3A560-AFA2-4E9D-BFDE-DEFEF1468635Q28829964-9EA4C968-710D-48EC-8647-973BC271B253Q35865445-FA3B8D82-261F-4D45-98E6-9519E82159A2Q38102053-11D22B44-D02E-496D-8E60-632B4EB673FCQ38167396-0F8A6373-660C-430F-ADC5-D9A574B7A051Q38167397-5FB43D9A-FC6B-4092-AD3D-EEED8CDE10BCQ38199658-2CCD504A-3F3F-43D1-A264-3AD24CD466A1Q38261541-FF9A91C9-84BE-4290-83A0-62DDC2755540Q38545685-02DE98B9-690A-4A2C-BC44-02B5BAC4C102Q40422912-1001539F-D0E2-4F3E-A248-1509FB4A171DQ41146292-98B006BC-0132-49B6-8621-E7F26775548FQ45824130-9235B223-3B7A-4CE5-8CAF-1B39C820D129Q55397242-A8391302-921B-4FC1-8B66-D510C20F9B67
P2860
Endocannabinoid system modulator use in everyday clinical practice in the UK and Spain.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Endocannabinoid system modulator use in everyday clinical practice in the UK and Spain.
@en
type
label
Endocannabinoid system modulator use in everyday clinical practice in the UK and Spain.
@en
prefLabel
Endocannabinoid system modulator use in everyday clinical practice in the UK and Spain.
@en
P2860
P356
P1476
Endocannabinoid system modulator use in everyday clinical practice in the UK and Spain.
@en
P2093
Antonio García-Merino
P2860
P356
10.1586/ERN.13.4
P433
P577
2013-02-01T00:00:00Z